Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 475.00 | |
100 mg | In stock | $ 695.00 |
Description | CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield. |
Molecular Weight | 410.27 |
Formula | C23H25BF2N2O2 |
CAS No. | 1193447-34-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.67 mg/ml
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CRANAD 2 1193447-34-5 Others inhibit CRANAD-2 Abeta Amyloid-β β-amyloid peptide Inhibitor CRANAD2 inhibitor